Bifidobacterium longum
BB536
Clinically researched probiotic strain supporting gut and immune health, widely used in adults and infants.
Bifidobacterium longum BB536 is a probiotic bacteria isolated from healthy infants, extensively studied for its benefits on digestive and immune health in both adults and children. It is considered safe, with regulatory approvals and robust clinical data supporting its use.
Over 200 clinical studies, regulatory recognition (FDA GRAS, EFSA), and consistent benefit signals in various populations support its safety and efficacy, especially for digestive health.
Supports gut and digestive health
StrongShown to help alleviate symptoms of irritable bowel syndrome, improve bowel regularity, and support the balance of gut microbiota.
Enhances immune function and reduces risk of some infections
ModerateMay lower incidence and duration of mild respiratory infections and stimulate key immune cell responses.
Safe for infants, helps with colic and gut issues
ModerateProven safety and efficacy in infant formulas; may help reduce colic, improve digestion, and reduce risk of necrotizing enterocolitis in preterm infants.
May support healthy cholesterol levels
LimitedEmerging research suggests potential for modest cholesterol lowering, though findings are preliminary.
Son güncelleme: